Table 1.
Data from PCPT using GS greater than or equal to 7 as the definition of high-grade prostate cancer
| Persons without a biopsy and without surgery (mxa) | ||||
| Randomization group (x) | Biopsy recommendation (a) | |||
| Placebo | No | 3955 | ||
| Yes | 215 | |||
| Finasteride |
No | 4169 | ||
| Yes |
214 |
|||
| Persons with biopsy but no surgery (nxay) | ||||
| Randomization group (x) | Biopsy recommendation (a) | Biopsy outcome (y) |
||
| No cancer | GS < 7 | GS ≥ 7 | ||
| Placebo | No | 3675 | 417 | 78 |
| Yes | 479 | 249 | 104 | |
| Finasteride |
No | 3791 | 230 | 75 |
| Yes |
458 |
145 |
132 |
|
| Persons with biopsy and surgery (kxayd) | ||||
| Randomization group (x) | Biopsy recommendation (a) | Surgery outcome (d) |
||
| Biopsy outcome (y) | GS < 7 | GS ≥ 7 | ||
| Placebo | No | GS < 7 | 83 | 19 |
| GS ≥ 7 | 8 | 13 | ||
| Yes | GS < 7 | 83 | 33 | |
| GS ≥ 7 | 9 | 46 | ||
| Finasteride | No | GS < 7 | 50 | 6 |
| GS ≥ 7 | 7 | 14 | ||
| Yes | GS < 7 | 44 | 23 | |
| GS ≥ 7 | 10 | 55 | ||